SaddleRock Capital Management LLC Invests $5.44 Million in Sotera Health Company $SHC

SaddleRock Capital Management LLC acquired a new stake in Sotera Health Company (NASDAQ:SHC) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 306,553 shares of the company’s stock, valued at approximately $5,441,000. Sotera Health accounts for 5.3% of SaddleRock Capital Management LLC’s investment portfolio, making the stock its 10th largest position.

Other institutional investors have also recently added to or reduced their stakes in the company. IFP Advisors Inc lifted its position in Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after buying an additional 1,371 shares during the period. Rothschild Investment LLC purchased a new stake in Sotera Health in the 4th quarter valued at about $27,000. Root Financial Partners LLC grew its holdings in Sotera Health by 217.5% in the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after buying an additional 1,455 shares during the period. Meeder Asset Management Inc. acquired a new position in shares of Sotera Health during the 2nd quarter valued at about $37,000. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after acquiring an additional 2,935 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Trading Down 2.0%

NASDAQ SHC opened at $19.17 on Tuesday. Sotera Health Company has a 52 week low of $13.09 and a 52 week high of $19.85. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. The stock has a market cap of $5.47 billion, a P/E ratio of 33.63 and a beta of 1.77. The company’s fifty day simple moving average is $17.82 and its 200-day simple moving average is $16.35.

Sotera Health (NASDAQ:SHC) last released its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The company had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. During the same quarter in the previous year, the firm earned $0.20 EPS. The company’s revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Equities research analysts predict that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Michael P. Rutz sold 150,000 shares of the firm’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the transaction, the insider owned 334,279 shares in the company, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 1,294,515 shares of company stock valued at $23,999,528. 15.36% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on SHC shares. Citigroup raised their target price on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Barclays upped their price target on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Piper Sandler reiterated an “overweight” rating and issued a $25.00 price target (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. Finally, UBS Group set a $19.00 price objective on shares of Sotera Health in a research note on Wednesday, June 24th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and a consensus price target of $21.50.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.